EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

CB2 Cannabinoid Receptor as a Potential Target in Myocardial Infarction: Exploration of Molecular Pathogenesis and Therapeutic Strategies

Sagar A More, Rucha S Deore, Harshal D Pawar iD, Charu Sharma, Kartik T Nakhate iD, Sumit S Rathod, Shreesh Ojha iD, Sameer N Goyal iD

International Journal of Molecular Sciences · 30.01.2024 · 25 (3) · 1683

DOI: 10.3390/ijms25031683 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.01.2024. Verfasst von Sagar A More und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Shri Vile Parle Kelavani Mandal's Institute of Pharmacy, Dhule 424001, Maharashtra, India. Hauptthemen laut MEDLINE: Cannabinoids, Myocardial Infarction, Receptor, Cannabinoid, CB1. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 172 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United Arab Emirates University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The lipid endocannabinoid system has recently emerged as a novel therapeutic target for several inflammatory and tissue-damaging diseases, including those affecting the cardiovascular system. The primary targets of cannabinoids are cannabinoid type 1 (CB1) and 2 (CB2) receptors. The CB2 receptor is expressed in the cardiomyocytes. While the pathological changes in the myocardium upregulate the CB2 receptor, genetic deletion of the receptor aggravates the changes. The CB2 receptor plays a crucial role in attenuating the advancement of myocardial infarction (MI)-associated pathological changes in the myocardium. Activation of CB2 receptors exerts cardioprotection in MI via numerous molecular pathways. For instance, delta-9-tetrahydrocannabinol attenuated the progression of MI via modulation of the CB2 receptor-dependent anti-inflammatory mechanisms, including suppression of pro-inflammatory cytokines like IL-6, TNF-α, and IL-1β. Through similar mechanisms, natural and synthetic CB2 receptor ligands repair myocardial tissue damage. This review aims to offer an in-depth discussion on the ameliorative potential of CB2 receptors in myocardial injuries induced by a variety of pathogenic mechanisms. Further, the modulation of autophagy, TGF-β/Smad3 signaling, MPTP opening, and ROS production are discussed. The molecular correlation of CB2 receptors with cardiac injury markers, such as troponin I, LDH1, and CK-MB, is explored. Special attention has been paid to novel insights into the potential therapeutic implications of CB2 receptor activation in MI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabinoidsMyocardial InfarctionReceptor, Cannabinoid, CB1HumansEndocannabinoidsMyocardiumReceptor, Cannabinoid, CB2Receptors, CannabinoidDronabinol

Stichwörter der Autor:innen

CB2 receptorsROScardiac markerscytokinesmyocardial infarction

Substanzen

CannabinoidsEndocannabinoidsReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2Receptors, CannabinoidDronabinol

Autor:innen und Institutionen

  • Department of Pharmacology, Shri Vile Parle Kelavani Mandal's Institute of Pharmacy, Dhule 424001, Maharashtra, India.
  • Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.
  • Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.

ORCID-Profile: Harshal D Pawar, Kartik T Nakhate, Shreesh Ojha, Sameer N Goyal

Förderung

  • United Arab Emirates University

Zitieren

APA

More, S. A., Deore, R. S., Pawar, H. D., Sharma, C., Nakhate, K. T., Rathod, S. S., Ojha, S., & Goyal, S. N. (2024). CB2 Cannabinoid Receptor as a Potential Target in Myocardial Infarction: Exploration of Molecular Pathogenesis and Therapeutic Strategies. International Journal of Molecular Sciences, 25(3), 1683. https://doi.org/10.3390/ijms25031683

Vancouver

More SA, Deore RS, Pawar HD, Sharma C, Nakhate KT, Rathod SS, et al. CB2 Cannabinoid Receptor as a Potential Target in Myocardial Infarction: Exploration of Molecular Pathogenesis and Therapeutic Strategies. International Journal of Molecular Sciences. 2024;25(3):1683. doi:10.3390/ijms25031683

BibTeX
@article{More2024,
  author = {More, Sagar A and Deore, Rucha S and Pawar, Harshal D and Sharma, Charu and Nakhate, Kartik T and Rathod, Sumit S and Ojha, Shreesh and Goyal, Sameer N},
  title = {CB2 Cannabinoid Receptor as a Potential Target in Myocardial Infarction: Exploration of Molecular Pathogenesis and Therapeutic Strategies},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {3},
  pages = {1683},
  doi = {10.3390/ijms25031683}
}
Kostenlos starten →